Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Landec Corporation (LNDC)

  • Company Report
  • March 16, 2023, 23:24 UTC
  • 44

New Form 10-Q for Lifecore Biomedical

Comment Full text

Landec Corporation (LNDC)

  • Company Report
  • March 16, 2023, 23:20 UTC
  • 41

New Form 10-Q/A for Lifecore Biomedical

Comment Full text

Landec Corporation (LNDC)

  • Company Report
  • March 16, 2023, 23:20 UTC
  • 41

New Form 10-K/A for Lifecore Biomedical

Comment Full text

Anika Therapeutics Inc. (ANIK)

  • Company Report
  • March 16, 2023, 22:55 UTC
  • 41

New SEC Filing for Anika Therapeutics Inc. (NASDAQ:ANIK)

Comment Full text

Journey Medical Corporation (DERM)

  • Company Report
  • March 16, 2023, 21:54 UTC
  • 40

Journey Medical Corporation Announces Completion of Treatment Assessing Impact of DFD-29 (Minocycline Modified Release Capsules 40 mg) on Microbial Flora in a Separate Phase 1 Clinical Trial

Comment Full text

Paratek Pharmaceuticals Inc (PRTK)

  • Company Report
  • March 16, 2023, 21:54 UTC
  • 41

Paratek Pharmaceuticals SEC filing

Comment Full text

Iterum Therapeutics plc (ITRM)

  • Company Report
  • March 16, 2023, 21:54 UTC
  • 41

New SEC Form for Iterum Therapeutics plc

Comment Full text

Cabaletta Bio Inc (CABA)

  • Company Report
  • March 16, 2023, 21:54 UTC
  • 42

New SEC Form for Cabaletta Bio, Inc.

Comment Full text

ADMA Biologics Inc (ADMA)

  • Company Report
  • March 16, 2023, 21:54 UTC
  • 38

ADMA Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023

Comment Full text

Nuvalent Inc (NUVL)

  • Company Report
  • March 16, 2023, 21:54 UTC
  • 43

New SEC Filing for Nuvalent Inc. (NASDAQ:NUVL)

Comment Full text
  • Previous
  • 17
  • 18
  • 19
  • 20
  • 21
  • Next

Search

News categories

  • Technical Exchange News(9094)
  • Event(407)
  • SEC News(144323)
  • FDA Approval(8438)
  • Company Report(721)
  • Business News(100881)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin